Tip 21 – Ephedrine Hydrochloride to make ECA Fat Burners – Ciccone Pharma decided to discontinue its ECA Fat Burners. The reason for this is that Eph HCL is now a banned substance all over the world. It is the main ingredient that fuels the narcotics trade and gets used in the manufacturing of Chrystal Meth, Tik and CAT. We are unable to purchase this ingredient anywhere in the world legitimately from any legal API (Active Pharmaceutical Ingredient) manufacturers. In the Far East Eph HCL is regarded as a narcotic and possession of it is a criminal offense. It is not a controlled substance like other pharmaceuticals. It is a banned substance.
Dianabol is not an extremely androgenic steroid, its androgenicity has been structurally reduced, but androgenic side effects are still possible. Such side effects of Dianabol use include acne, accelerated hair loss in those predisposed to male pattern baldness and body hair growth. Most men should not have a problem with such effects, response will be the final dictator, but most will remain clear. Although the odds are in your favor, such effects are brought on by Methandrostenolone being metabolized by the 5-alpha reductase enzyme. This is the same enzyme responsible for the reduction of testosterone to dihydrotestosterone, but the overall conversion here will result in very low amounts of dihydromethandrostenolone. This tells us 5-alpha reductase inhibitors like Finasteride that are often used to combat androgenic side effects will have very little if any affect on Dianabol.
Despite its reduced androgenicity, Dianabol can promote virilization symptoms in women. Such symptoms include body hair growth, a deepening of the vocal chords and clitoral enlargement. It is possible for some women to use this steroid without virilization symptoms with extremely low doses, but the odds are not favorable. Most all women should choose anabolic steroids with less translating androgenic activity to meet their needs.
Write a review below
Note: HTML is not translated!
Captcha Enter the code in the box below Continue